Cargando…
Prevalence and Serological Diagnosis of Relapse in Paracoccidioidomycosis Patients
A review of 400 clinical records of paracoccidioidomycosis (PCM) patients, 93 with the acute/subacute (AF) and 307 with the chronic form (CF), attended from 1977 to 2011, selected as to the schedule of release for study by the Office of Medical Records at the University Hospital of the Faculdade de...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006716/ https://www.ncbi.nlm.nih.gov/pubmed/24787147 http://dx.doi.org/10.1371/journal.pntd.0002834 |
_version_ | 1782314250549592064 |
---|---|
author | Sylvestre, Tatiane Fernanda Silva, Luciane Regina Franciscone Cavalcante, Ricardo de Souza Moris, Daniela Vanessa Venturini, James Vicentini, Adriana Pardini de Carvalho, Lídia Raquel Mendes, Rinaldo Poncio |
author_facet | Sylvestre, Tatiane Fernanda Silva, Luciane Regina Franciscone Cavalcante, Ricardo de Souza Moris, Daniela Vanessa Venturini, James Vicentini, Adriana Pardini de Carvalho, Lídia Raquel Mendes, Rinaldo Poncio |
author_sort | Sylvestre, Tatiane Fernanda |
collection | PubMed |
description | A review of 400 clinical records of paracoccidioidomycosis (PCM) patients, 93 with the acute/subacute (AF) and 307 with the chronic form (CF), attended from 1977 to 2011, selected as to the schedule of release for study by the Office of Medical Records at the University Hospital of the Faculdade de Medicina de Botucatu – São Paulo State University – UNESP, was performed to detect cases in relapse. The control of cure was performed by clinical and serological evaluation using the double agar gel immunodiffusion test (DID). In the diagnosis of relapse, DID, enzyme-linked immunosorbent assay (ELISA) and immunoblotting assay (IBgp70 and IBgp43) were evaluated. Out of 400 patients, 21 (5.2%) went through relapse, 18 of them were male and 3 were female, 6∶1 male/female ratio. Out of the 21 patients in relapse, 15 (4.8%) showed the CF, and 6 (6.4%) the AF (p>0.05). The sensitivity of DID and ELISA before treatment was the same (76.1%). DID presented higher sensitivity in pre-treatment (80%) than at relapse (45%; p = 0.017), while ELISA showed the same sensitivity (80% vs 65%; p = 0.125). The serological methods for identifying PCM patients in relapse showed low rates of sensitivity, from 12.5% in IBgp70 to 65.0% in IBgp43 identification and 68.8% in ELISA. The sensitivity of ELISA in diagnosing PCM relapse showed a strong tendency to be higher than DID (p = 0.06) and is equal to IBgp43 (p = 0.11). In sum, prevalence of relapse was not high in PCM patients whose treatment duration was based on immunological parameters. However, the used methods for serological diagnosis present low sensitivity. While more accurate serological methods are not available, we pay special attention to the mycological and histopathological diagnosis of PCM relapse. Hence, direct mycological, cytopathological, and histopathological examinations and isolation in culture for P. brasiliensis must be appropriately and routinely performed when the hypothesis of relapse is considered. |
format | Online Article Text |
id | pubmed-4006716 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-40067162014-05-09 Prevalence and Serological Diagnosis of Relapse in Paracoccidioidomycosis Patients Sylvestre, Tatiane Fernanda Silva, Luciane Regina Franciscone Cavalcante, Ricardo de Souza Moris, Daniela Vanessa Venturini, James Vicentini, Adriana Pardini de Carvalho, Lídia Raquel Mendes, Rinaldo Poncio PLoS Negl Trop Dis Research Article A review of 400 clinical records of paracoccidioidomycosis (PCM) patients, 93 with the acute/subacute (AF) and 307 with the chronic form (CF), attended from 1977 to 2011, selected as to the schedule of release for study by the Office of Medical Records at the University Hospital of the Faculdade de Medicina de Botucatu – São Paulo State University – UNESP, was performed to detect cases in relapse. The control of cure was performed by clinical and serological evaluation using the double agar gel immunodiffusion test (DID). In the diagnosis of relapse, DID, enzyme-linked immunosorbent assay (ELISA) and immunoblotting assay (IBgp70 and IBgp43) were evaluated. Out of 400 patients, 21 (5.2%) went through relapse, 18 of them were male and 3 were female, 6∶1 male/female ratio. Out of the 21 patients in relapse, 15 (4.8%) showed the CF, and 6 (6.4%) the AF (p>0.05). The sensitivity of DID and ELISA before treatment was the same (76.1%). DID presented higher sensitivity in pre-treatment (80%) than at relapse (45%; p = 0.017), while ELISA showed the same sensitivity (80% vs 65%; p = 0.125). The serological methods for identifying PCM patients in relapse showed low rates of sensitivity, from 12.5% in IBgp70 to 65.0% in IBgp43 identification and 68.8% in ELISA. The sensitivity of ELISA in diagnosing PCM relapse showed a strong tendency to be higher than DID (p = 0.06) and is equal to IBgp43 (p = 0.11). In sum, prevalence of relapse was not high in PCM patients whose treatment duration was based on immunological parameters. However, the used methods for serological diagnosis present low sensitivity. While more accurate serological methods are not available, we pay special attention to the mycological and histopathological diagnosis of PCM relapse. Hence, direct mycological, cytopathological, and histopathological examinations and isolation in culture for P. brasiliensis must be appropriately and routinely performed when the hypothesis of relapse is considered. Public Library of Science 2014-05-01 /pmc/articles/PMC4006716/ /pubmed/24787147 http://dx.doi.org/10.1371/journal.pntd.0002834 Text en © 2014 Sylvestre et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Sylvestre, Tatiane Fernanda Silva, Luciane Regina Franciscone Cavalcante, Ricardo de Souza Moris, Daniela Vanessa Venturini, James Vicentini, Adriana Pardini de Carvalho, Lídia Raquel Mendes, Rinaldo Poncio Prevalence and Serological Diagnosis of Relapse in Paracoccidioidomycosis Patients |
title | Prevalence and Serological Diagnosis of Relapse in Paracoccidioidomycosis Patients |
title_full | Prevalence and Serological Diagnosis of Relapse in Paracoccidioidomycosis Patients |
title_fullStr | Prevalence and Serological Diagnosis of Relapse in Paracoccidioidomycosis Patients |
title_full_unstemmed | Prevalence and Serological Diagnosis of Relapse in Paracoccidioidomycosis Patients |
title_short | Prevalence and Serological Diagnosis of Relapse in Paracoccidioidomycosis Patients |
title_sort | prevalence and serological diagnosis of relapse in paracoccidioidomycosis patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006716/ https://www.ncbi.nlm.nih.gov/pubmed/24787147 http://dx.doi.org/10.1371/journal.pntd.0002834 |
work_keys_str_mv | AT sylvestretatianefernanda prevalenceandserologicaldiagnosisofrelapseinparacoccidioidomycosispatients AT silvalucianereginafranciscone prevalenceandserologicaldiagnosisofrelapseinparacoccidioidomycosispatients AT cavalcantericardodesouza prevalenceandserologicaldiagnosisofrelapseinparacoccidioidomycosispatients AT morisdanielavanessa prevalenceandserologicaldiagnosisofrelapseinparacoccidioidomycosispatients AT venturinijames prevalenceandserologicaldiagnosisofrelapseinparacoccidioidomycosispatients AT vicentiniadrianapardini prevalenceandserologicaldiagnosisofrelapseinparacoccidioidomycosispatients AT decarvalholidiaraquel prevalenceandserologicaldiagnosisofrelapseinparacoccidioidomycosispatients AT mendesrinaldoponcio prevalenceandserologicaldiagnosisofrelapseinparacoccidioidomycosispatients |